It is important to note that the Food and Drug Administration (FDA) has historically had a bias against cannabis and has been slow to recognize the potential therapeutic benefits of the plant. This is likely due to the longstanding federal prohibition on cannabis, which has made it difficult for researchers to study the plant and for the FDA to regulate it as a medicine.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…